Skip to main content

Table 3 Prevalence of mutations not in the MAPK pathway in ATC

From: Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review

Mutation

Positive/ total cases

Prevalence (%)

Reference

PTEN

8/48

17

[44]

 

8/50

16

[61]

 

1/9

10

[65]

Overall PTEN

17/107

16

 

PI3KCA

6/50

12

[44]

 

4/18

22

[58]

 

29/50

58

[61]

 

16/70

23

[66]

Overall PI3KCA

45/188

24

 

TP53

1/11

10

[67]

 

5/7

71

[19]

 

6/7

86

[68]

Overall TP53

12/25

48

 
Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us